Exagen Inc (XGN)
Exagen Inc. Reports Strong Q3 2025 Results
Exagen Inc. Reports Strong Q3 2025 Results
Geron Corporation to Present at Upcoming Investor Conferences
Lipocine Presents LPCN 2401 Clinical Data at ObesityWeek®
Twist Bioscience to Present at 7th Annual Wolfe Research Healthcare Conference
UroGen Pharma to Present at Guggenheim Securities Healthcare Innovation Conference
Ardelyx President and Chief Executive Officer Mike Raab to Participate in the Wedbush Rewind American Society of Nephrology 2025 Investor Conference
Calidi Biotherapeutics Announces Investor Event to be Held on Friday, November 7th at the 2025 SITC Annual Meeting
Certara Automates Scientific Workflows with Phoenix® Cloud
Xtant Medical to Announce Third Quarter 2025 Financial Results on November 11, 2025
Jasper Therapeutics to Present at Upcoming Investor Conferences